New drug trial aims to stop dangerous blood pressure crashes during dialysis
NCT ID NCT05297786
Summary
This study is testing if a drug called lanadelumab can prevent severe drops in blood pressure that some patients experience during kidney dialysis. The trial involves 28 adults on regular dialysis who frequently get dizzy, nauseous, or cramp when their blood pressure falls during treatment. Researchers will compare the drug to a placebo to see if it helps maintain more stable blood pressure levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODIALYSIS COMPLICATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.